Bayer’s Non-cystic Fibrosis Bronchiectasis, Pneumonia Drugs Gain QIDP Status From FDA
Bronchiectasis, News
Recently, two Bayer experimental drugs, Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation (DPI), were granted the title of qualified infectious disease products (QIDP) by the U.S. Food and Drug Administration ... Read more